These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15641485)

  • 21. Enhanced susceptibility of adriamycin-treated human renal cell carcinoma cells to lysis by peripheral blood lymphocytes and tumor infiltrating lymphocytes.
    Wu XX; Zeng Y; Jin XH; Kakehi Y
    Oncol Rep; 2007 Aug; 18(2):353-9. PubMed ID: 17611656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the immune reactivity of infiltrating and peripheral lymphocytes from patients with renal cell carcinoma by measuring cytokine secretion.
    Elsässer-Beile U; Wetterauer U; Schultze-Seemann W; Gallati H; Mönting JS; von Kleist S
    Cancer Immunol Immunother; 1996 Feb; 42(2):93-8. PubMed ID: 8620526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis.
    Gardini A; Ercolani G; Riccobon A; Ravaioli M; Ridolfi L; Flamini E; Ridolfi R; Grazi GL; Cavallari A; Amadori D
    J Surg Oncol; 2004 Jul; 87(1):46-52. PubMed ID: 15221919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy.
    Bukowski RM; Rayman P; Uzzo R; Bloom T; Sandstrom K; Peereboom D; Olencki T; Budd GT; McLain D; Elson P; Novick A; Finke JH
    Clin Cancer Res; 1998 Oct; 4(10):2337-47. PubMed ID: 9796963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The expression of zeta-chain of the T cell receptor as prognostic marker for patients with head and neck cancer].
    Müller D; Lang S; Roskrow M; Wollenberg B
    Laryngorhinootologie; 2002 Jul; 81(7):516-20. PubMed ID: 12173063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alteration of signal-transducing molecules and phenotypical characteristics in peripheral blood lymphocytes from gastric carcinoma patients.
    Kim CW; Choi SH; Chung EJ; Lee MJ; Byun EK; Ryu MH; Bang YJ
    Pathobiology; 1999; 67(3):123-8. PubMed ID: 10394132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.
    Weidmann E; Whiteside TL; Giorda R; Herberman RB; Trucco M
    Cancer Res; 1992 Nov; 52(21):5913-20. PubMed ID: 1382847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy.
    Leisegang M; Turqueti-Neves A; Engels B; Blankenstein T; Schendel DJ; Uckert W; Noessner E
    Clin Cancer Res; 2010 Apr; 16(8):2333-43. PubMed ID: 20371691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
    Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A
    J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of proximal T cell receptor signaling and lytic function in CD8+ tumor-infiltrating T cells.
    Monu N; Frey AB
    Cancer Res; 2007 Dec; 67(23):11447-54. PubMed ID: 18056473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity.
    Belldegrun A; Muul LM; Rosenberg SA
    Cancer Res; 1988 Jan; 48(1):206-14. PubMed ID: 3257161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotype analysis of tumour-infiltrating lymphocytes and lymphocytes in peripheral blood in patients with renal carcinoma.
    Kopecký O; Lukesová S; Vroblová V; Vokurková D; Morávek P; Safránek H; Hlávková D; Soucek P
    Acta Medica (Hradec Kralove); 2007; 50(3):207-12. PubMed ID: 18254275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. gp120 ligation of CD4 induces p56lck activation and TCR desensitization independent of TCR tyrosine phosphorylation.
    Goldman F; Jensen WA; Johnson GL; Heasley L; Cambier JC
    J Immunol; 1994 Oct; 153(7):2905-17. PubMed ID: 7522245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased expression of activation markers in renal cell carcinoma infiltrating lymphocytes.
    Shabtai M; Ye H; Frischer Z; Martin J; Waltzer WC; Malinowski K
    J Urol; 2002 Nov; 168(5):2216-9. PubMed ID: 12394762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma.
    Giraldo NA; Becht E; Vano Y; Petitprez F; Lacroix L; Validire P; Sanchez-Salas R; Ingels A; Oudard S; Moatti A; Buttard B; Bourass S; Germain C; Cathelineau X; Fridman WH; Sautès-Fridman C
    Clin Cancer Res; 2017 Aug; 23(15):4416-4428. PubMed ID: 28213366
    [No Abstract]   [Full Text] [Related]  

  • 37. Immune cells in the tumor microenvironment. Mechanisms responsible for functional and signaling defects.
    Whiteside TL
    Adv Exp Med Biol; 1998; 451():167-71. PubMed ID: 10026868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors.
    Alexander JP; Kudoh S; Melsop KA; Hamilton TA; Edinger MG; Tubbs RR; Sica D; Tuason L; Klein E; Bukowski RM
    Cancer Res; 1993 Mar; 53(6):1380-7. PubMed ID: 8443817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
    Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
    Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T lymphocytes infiltrating renal cell carcinoma have a reduced expression of transferrin receptor.
    Kudoh S; Stanley J; Edinger MG; Tubbs RR; Klein E; Bukowski RM; Finke JH
    Int J Cancer; 1994 Aug; 58(3):369-75. PubMed ID: 8050820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.